Skip to main content

Articles By Jack Cush, MD

mask.cough_.URI_.jpg

ICYMI: Preventing COVID - Masks, Meters and Eyewear

By Jack Cush, MD
09 July 2020

A Lancet systematic review and meta-analysis provides the basis for physical distancing and the value of making as measures to prevent infection with coronavirus 2 (SARS-CoV-2) or COVID-19. The analysis included 172 observational studies, no randomised controlled trials and 44 relevant comparative studies involving 25 697 patients. 

Read Article
Clot.DVT_.VTE_.blood__1.jpg

ICYMI: COVID-19 and Thrombotic Complications

By Jack Cush, MD
08 July 2020

Severe and fatal outcomes with coronavirus infection are often the result of the downstream damage that follows the viral infection. Rising high on the list of complications are the hematologic and vascular complications seen in severely affected patients, so much so that many centers are routinely anticoagulating hospitalized (but not ambulatory) COVID patients.

Read Article
Revise.restart.rebuild.redo_.jpg

ICYMI: Shutdown and the New Normal

By Jack Cush, MD
07 July 2020

COVID-19 is not going to suddenly end on June 1st. This is a long haul change and you need to be prepared for the aftershocks and fallout. It’s time to be be a Marine and ”Improvise, Adapt, and Overcome”.

Read Article
ICU

ICYMI: Outcomes of Critically-Ill COVID Patients in NYC

By Jack Cush, MD
06 July 2020

Lancet has reported COVID outcomes from NewYork-Presbyterian hospitals in NYC during March 2020 showing high rates of hospitalization, ICU admission, mechanical ventilation and death.  A prospective observational cohort study 2 2 NYC hospitals from March 2 to April 1, 2020, looking at laboratory-confirmed COVID-19 and were critically ill with acute hypoxaemic respiratory failure, and collected clinical, biomarker, and treatment data. The primary outcome was in-hospital death.

Read Article
podcast logo

RheumNow Podcast – Gout Guidelines (7.3.20)

By Jack Cush, MD
03 July 2020

Dr Jack Cush reviews the journal reports and news from RheumNow this past week. Highlights include:

Read Article
Gout.Guidelines.png

2020 ACR Gout Management Guideline

By Jack Cush, MD
03 July 2020

In May, the American College of Rheumatology (ACR) released the"2020 Guideline for the Management of Gout"reflecting new clinical evidence since the last guideline published in 2012.

Read Article
RA.gout.hand.MCP

Coexistent Gout and Rheumatoid Arthritis

By Jack Cush, MD
02 July 2020

While it is often said there is a negative association between gout and rheumatoid arthritis (RA), cases of coexistent disorders are uncommonly seen. A recent VA study describes 121 patients whith both RA and gout.

Read Article
heart.EKG_.CVD__2.jpg

CV Risks Raised in Myopathies

By Jack Cush, MD
02 July 2020

Patients with the idiopathic inflammatory myopathies (IIMs) dermatomyositis and polymyositis are at increased risk for cardiovascular events, with risks similar to what has been documented for rheumatoid arthritis (RA), during the first 5 years after diagnosis, U.K. researchers reported.

Read Article
Liver.hepatitis.jpg

Liver Abnormalities in Psoriatic Arthritis

By Jack Cush, MD
01 July 2020

A new report in the Journal of Rheumatology shows that liver abnormalities are common in psoriatic arthritis (PsA) and may be associated with obesity, more severe disease and select therapies.

Read Article
RA.vascular.cholesterol.plaque_3.jpg

Premature Atherosclerosis in Autoimmune Rheumatic Diseases

By Jack Cush, MD
01 July 2020

The VITAL study is a VA registry that has shown that both systemic lupus erythematosus  (SLE) and rheumatoid arthritis (RA) patients carry higher odds of both premature and extremely premature atherosclerotic cardiovascular disease and its consequences.

Read Article
×